Clinical trials for Aspartic Acid

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 43881 clinical trials with a EudraCT protocol, of which 7295 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (16)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

16 result(s) found for: Aspartic Acid. Displaying page 1 of 1.

EudraCT Number: 2009-012602-39

Sponsor Protocol Number: 05-NEOV-002

Start Date*: 2010-05-17

Sponsor Name:Fresenius Kabi Deutschland GmbH

Full Title: A randomised, double-blind study evaluating the safety, tolerability, protein accretion, amino acid plasma levels and long-term outcome of Neoven compared to Vaminolact(R) in premature very low bir...

Medical condition: The product is aimed to be used where parenteral nutrition is required. The intended indication is: Supply of essential and non-essential amino acids as part of parenteral nutrition for premature ...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.1		10051284	Parenteral nutrition	LLT

Population Age: Preterm newborn infants, Under 18

Gender: Male, Female

Trial protocol: DE (Prematurely Ended) NL (Prematurely Ended)

Trial results: View results

EudraCT Number: 2021-002395-39	Sponsor Protocol Number: WN43174	Start Date*: 2022-05-24
Sponsor Name:F. HOFFMANN - LA ROCHE LTD.
Full Title: A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER BASKET STUDY TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SATRALIZUMAB IN PATIENTS WITH ANTI-N-...
Medical condition: NMDAR or LGI1 mediated autoimmune Encephalitis
Disease:
Population Age: Adolescents, Under 18, Adults, Elderly		Gender: Male, Female
Trial protocol: IT (Ongoing) CZ (Ongoing) PL (Ongoing) AT (Ongoing) NL (Ongoing) FR (Ongoing) DK (Ongoing)
Trial results: (No results available)

EudraCT Number: 2009-012603-26

Sponsor Protocol Number: 05-NEOV-003

Start Date*: 2010-04-08

Sponsor Name:Fresenius Kabi Deutschland GmbH [...]

Full Title: A randomised, double-blind study evaluating the safety, tolerability and clinical outcome of Neoven compared to Vaminolact in premature ELBW infants

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.1		10051284	Parenteral nutrition	LLT

Population Age: Preterm newborn infants, Under 18

Gender: Male, Female

Trial protocol: BE (Completed) DE (Prematurely Ended) FR (Prematurely Ended)

Trial results: View results

EudraCT Number: 2009-012604-92

Sponsor Protocol Number: 05-NEOV-004

Start Date*: 2010-04-19

Sponsor Name:Fresenius Kabi Deutschland GmbH

Full Title: A randomised, double-blind study of the safety and efficacy of Neoven compared to Vaminolact in infants and children requiring long-term parenteral nutrition

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.1		10051284	Parenteral nutrition	LLT

Population Age: Infants and toddlers, Children, Under 18

Gender: Male, Female

Trial protocol: FR (Prematurely Ended)

Trial results: View results

EudraCT Number: 2015-005325-39

Sponsor Protocol Number: ELX-NPP-2016-01

Start Date*: 2016-04-26

Sponsor Name:Dr. Antonio Arroyo Sebastián

Full Title: A RANDOMIZED, CONTROLLED, CLINICAL TRIAL TO COMPARE PERIPHERAL PARENTERAL NUTRITION (PeriOlimel N4-E) VS CONVENTIONAL FLUID THERAPY IN ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOL IN COLORECTAL ...

Medical condition: Cancer colorectal

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061451	Colorectal cancer	PT

Population Age: Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2008-000429-20

Sponsor Protocol Number: 05-NEOV-001

Start Date*: 2008-10-17

Sponsor Name:Fresenius Kabi Deutschland GmbH

Full Title: A randomised, double-blind study evaluating the safety, tolerability, and amino acid plasma levels of Neoven compared to Vaminolact in infants after surgical interventions.

Medical condition: The product is aimed to be used where parenteral nutrition is required. The indended indication is: Supply of essential and non-essential amino acids as part of parenteral nutrition for preterm an...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10051284	Parenteral nutrition	LLT

Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18

Gender: Male, Female

Trial protocol: NL (Completed) BE (Completed) DE (Completed)

Trial results: View results

EudraCT Number: 2012-001112-29	Sponsor Protocol Number: CL-N-HTX-CSM-III/04/12	Start Date*: 2015-07-27
Sponsor Name:Dr. Franz Köhler Chemie GmbH
Full Title: A Prospective, randomized, single blind, multicenter Phase III study of organ perfusion with Custodiol-N solution compared with Custodiol solution in Heart transplantation
Medical condition: Patients that has to undergo (is suitable for) a heart transplantation
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: DE (Completed) AT (Completed)
Trial results: View results

EudraCT Number: 2009-009918-40

Sponsor Protocol Number: LG-TAU-2008-04

Start Date*: 2009-07-22

Sponsor Name:LABORATORIOS GRIFOLS, S.A.

Full Title: Ensayo Clínico fase IV, prospectivo, aleatorizado, doble ciego, de grupos paralelos y unicéntrico, para evaluar el efecto de la taurina en Nutrición Parenteral Total sobre la función hepática en pa...

Medical condition: Evaluar el efecto de la taurina en nutrición Parenteral Total sobre la función hepática en pacientes postquirúrgicos. Evaluate the effect of taurine in Total Parenteral Nutrition on the hepatic fun...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9		10044107	Total parenteral nutrition	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2019-001872-12

Sponsor Protocol Number: CL-N-LTX-III/08-ESP/19

Start Date*: 2021-12-28

Sponsor Name:Dr. Franz Köhler Chemie GmbH

Full Title: A Prospective, randomized, single blind, multicenter Phase III study on organ preservation with Custodiol-N solution compared with Custodiol solution in liver transplantation

Medical condition: Liver transplantation.

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10042613 - Surgical and medical procedures	10024714	Liver transplant	PT
	21.0	10042613 - Surgical and medical procedures	10024716	Liver transplantation	LLT
	21.1	10042613 - Surgical and medical procedures	10050434	Prophylaxis against liver transplant rejection	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2008-006300-27

Sponsor Protocol Number: MC-ASP.6/INF

Start Date*: 2009-08-12

Sponsor Name:medac Gesellschaft für klinische Spezialpräparate mbH

Full Title: Efficacy and safety of recombinant asparaginase in infants (< 1 year) with previously untreated acute lymphoblastic leukaemia - Phase II Clinical Trial -

Medical condition: Acute lymphoblastic leukaemia (ALL) is a clonal disease resulting from genetic mutations and transformation of a single early progenitor lymphoid cell. Uncontrolled expansion of leukaemic blasts in...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10000844	Acute lymphoblastic leukaemia	LLT

Population Age: Newborns, Infants and toddlers, Under 18

Gender: Male, Female

Trial protocol: NL (Completed) DE (Completed)

Trial results: View results

EudraCT Number: 2012-003776-40	Sponsor Protocol Number: CL-N-CSM-AV-III/05/12	Start Date*: 2013-11-08
Sponsor Name:Dr. Franz Köhler Chemie GmbH
Full Title: A Prospective Randomized Double Blind Multicenter Phase III Study Comparing two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N versus Custodiol
Medical condition: Patients with aortic valve disease and has to undergo aortic valve surgery +/- bypass surgery.
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results

EudraCT Number: 2013-005503-13

Sponsor Protocol Number: 1.0_Custodiol

Start Date*: 2015-02-16

Sponsor Name:Essen University Hospital, University of Essen, Klinik für Allgemein-, Viszeral- und Transplantationschirugie

Full Title: A prospective randomized single blind monocenter phase II study of organ perfusion with Custodiol-N compared with Custodiol solution in living donor kidney transplantation

Medical condition: kidney preservation by Custodiol-N or Custodiol solution before living related kidney transplantation

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	17.1	100000004865	10023438	Kidney transplant	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: View results

EudraCT Number: 2018-004946-41	Sponsor Protocol Number: SP-PP18	Start Date*: 2019-09-12
Sponsor Name:Dr. Virgilio P. Carnielli,
Full Title: Personalized versus standard parenteral nutrition for preterm infants with a birth weight greater than 1250 grams: a phase IV randomized clinical trial
Medical condition: Growth of preterm infants with a birth weight greater than 1250g on parenteral nutrition.
Disease:
Population Age: Preterm newborn infants, Under 18		Gender: Male, Female
Trial protocol: ES (Ongoing) IT (Ongoing)
Trial results: (No results available)

EudraCT Number: 2006-003180-31

Sponsor Protocol Number: MC-ASP.5/ALL

Start Date*: 2008-07-29

Sponsor Name:medac GmbH

Full Title: Comparative efficacy and safety of two asparaginase preparations in children with previously untreated acute lymphoblastic leukaemia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10000844	Acute lymphoblastic leukaemia	LLT

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: NL (Completed)

Trial results: View results

EudraCT Number: 2017-002198-20	Sponsor Protocol Number: CLNKLPTXIII07AT17	Start Date*: 2018-11-28
Sponsor Name:Dr. Franz Köhler Chemie GmbH
Full Title: A Prospective, randomized, single blind, multicentre Phase III study on organ preservation with Custodiol-N solution compared with Custodiol solution in organ transplantation (kidney, liver and pan...
Medical condition: patients who will undergo kidney, liver or kidney-pancreatic transplantation
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: AT (Ongoing)
Trial results: (No results available)

EudraCT Number: 2022-001795-34

Sponsor Protocol Number: CL-N-HTX-Paed-II/10/20

Start Date*: 2023-01-30

Sponsor Name:Dr. Franz Köhler Chemie GmbH

Full Title: A prospective randomized single blind multicenter phase II study of organ perfusion with Custodiol-N compared with Custodiol in heart transplantation in children

Medical condition: Preservation of hearts prior to heart transplantation in children

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	10042613 - Surgical and medical procedures	10019314	Heart transplant	PT

Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: DE (Ongoing)

Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Mon May 20 04:33:08 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA